| Entry |
|
|---|
| Name |
Alrestatin sodium (USAN) |
|---|
| Formula |
C14H8NO4. Na
|
|---|
| Exact mass |
277.0351
|
|---|
| Mol weight |
277.21
|
|---|
| Structure |
|
|---|
| Class |
Antidiabetic agent
DG01882 Aldose reductase inhibitor
|
|---|
| Efficacy |
Antidiabetic, Aldose reductase inhibitor |
|---|
| Target |
|
|---|
| Pathway |
| hsa00051 | Fructose and mannose metabolism |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antidiabetic agent
DG01882 Aldose reductase inhibitor
D02835 Alrestatin sodium
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Dehydrogenases
AKR1B1
D02835 Alrestatin sodium (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 20
1 Z Na 27.3569 -16.3450 #+
2 C8y C 20.7200 -18.7600
3 C8x C 19.5076 -19.4600
4 C8x C 19.5076 -20.8600
5 C8x C 20.7200 -21.5600
6 C8y C 21.9324 -20.8600
7 C8y C 21.9324 -19.4600
8 C8x C 23.1449 -21.5600
9 C8x C 24.3573 -20.8600
10 C8x C 24.3573 -19.4600
11 C8y C 23.1449 -18.7600
12 C5x C 23.1449 -17.3600
13 N1y N 21.9324 -16.6600
14 C5x C 20.7200 -17.3600
15 O5x O 24.3573 -16.6600
16 O6a O 24.3573 -15.2600 #-
17 C6a C 23.1449 -14.5600
18 C1b C 21.9324 -15.2600
19 O5x O 19.5076 -16.6600
20 O6a O 23.1449 -13.1600
BOND 21
1 2 3 2
2 3 4 1
3 4 5 2
4 5 6 1
5 6 7 2
6 2 7 1
7 6 8 1
8 8 9 2
9 9 10 1
10 10 11 2
11 7 11 1
12 11 12 1
13 12 13 1
14 13 14 1
15 2 14 1
16 12 15 2
17 16 17 1
18 17 18 1
19 18 13 1
20 14 19 2
21 17 20 2
|
|---|
